Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prognosis in multiple sclerosis]

J Kesselring1

  • 1Rehabilitationszentrum Valens.

Schweizerische Medizinische Wochenschrift
|March 22, 1997
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis prognosis is assessed using the Expanded Disability Status Scale (EDSS). Early symptoms and patient factors influence outcomes, while new therapies reduce relapses but not overall disability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors influencing patient satisfaction with the first diagnostic consultation in multiple sclerosis: a Swiss Multiple Sclerosis Registry (SMSR) study.

Journal of neurology·2019
Same author

Effectiveness of telerehabilitation interventions in persons with multiple sclerosis: A systematic review.

Multiple sclerosis and related disorders·2015
Same author

Telerehabilitation for persons with multiple sclerosis. A Cochrane review.

European journal of physical and rehabilitation medicine·2015
Same author

[Multiple sclerosis : rehabilitation and long-term course].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2014
Same author

Fatigue in multiple sclerosis is not due to sleep apnoea.

European journal of neurology·2013
Same author

Endurance training in MS: short-term immune responses and their relation to cardiorespiratory fitness, health-related quality of life, and fatigue.

Journal of neurology·2013
Same journal

Respiratory function test in the case of temporary phrenic nerve contusion, associated with pneumoperitoneum; About the diagnostic value of laparoscopy.

Schweizerische medizinische Wochenschrift·2010
Same journal

Treatment of pulmonary tuberculosis and pleurisy by means of temporary paralysis of the diaphragm, supported by the pneumoperitoneum.

Schweizerische medizinische Wochenschrift·2010
Same journal

Boeck's disease as a tuberculous syndrome.

Schweizerische medizinische Wochenschrift·2010
Same journal

Enteral primary tubercular complexes

Schweizerische medizinische Wochenschrift·2010
Same journal

Tuberculous stenoses of the large bronchi.

Schweizerische medizinische Wochenschrift·2010
Same journal

About the enzyme action.

Schweizerische medizinische Wochenschrift·2010
See all related articles

Area of Science:

  • Neurology
  • Clinical Medicine

Context:

  • Multiple sclerosis (MS) prognosis is typically measured using Kurtzke's Expanded Disability Status Scale (EDSS).
  • The EDSS is a non-linear scale emphasizing mobility, with 20 steps.
  • Understanding prognostic factors is crucial for managing MS progression.

Purpose:

  • To review indicators of favorable prognosis in multiple sclerosis.
  • To evaluate the predictive value of initial MRI findings in clinically isolated syndromes.
  • To assess the impact of emerging therapies on MS disability and relapse rates.

Summary:

  • Favorable prognosis in MS is linked to optic neuritis/sensory disturbances as initial symptoms, younger age at onset, female sex, and longer intervals between relapses.
  • Initial brain MRI lesion load in clinically isolated syndromes predicts disease dissemination over 5-10 years.

Related Experiment Videos

  • Current therapies like interferon beta and copolymer 1 reduce relapse frequency and MRI lesion burden but do not significantly impact long-term disability.

    • Impact:

    • Provides insights into predicting multiple sclerosis disease course.
    • Highlights the prognostic significance of early clinical and radiological findings.
    • Clarifies the current limitations of disease-modifying therapies in altering MS disability progression.